Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Seoul
Clinical trial register · South Korea

Clinical Trials in Seoul, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 27 Seongnam 11 Busan 10 Incheon 8 Suwon 6
Narrow the registerReset
Recruitment status
Phase
Site location
Seoul27 Seongnam11 Busan10 Incheon8 Suwon6
All 26 locations
Target enrolment
to

Trials with a site in Seoul

27 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Gwangju, Seoul
2026-11-09
Recruiting
Boehringer Ingelheim
Phase 3
466
Bucheon-si, Gyeonggi-do, Busan, Seongnam, Seoul
2026-09-17
Recruiting
Boehringer Ingelheim
Phase 3
448
Seoul, Suwon
2026-07-27
Recruiting
Boehringer Ingelheim
Phase 2
132
Seoul, Suwon
2026-03-23
Recruiting
Boehringer Ingelheim
Phase 3
286
Busan, Gangnam-gu, Goyang, Seoul, Suwon
2026-02-16
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
80
Seoul
2026-02-10
Recruiting
Boehringer Ingelheim
Phase 3
400
Goyang, Seongnam, Seoul, Suwon
2026-01-16
Recruiting
Boehringer Ingelheim
Phase 3
120
Daegu, Gwangju, Seongnam, Seoul
2025-12-09
Active, closed
Boehringer Ingelheim
Phase 2
81
Bucheon-si, Gyeonggi-do, Busan, Seoul
2025-11-13
Recruiting
Boehringer Ingelheim
Phase 3
670
Busan, Daejoen, Goyang, Hwasun, Seongnam, Seoul
2025-11-07
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
413
Seongnam, Seoul
2025-09-13
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Anyang, Chungju, Daegu, Dong-gu Ulsan, Incheon, Seoul, Wŏnju
2025-06-09
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Busan, Gwangju, Incheon, Seongnam, Seoul, Wŏnju
2025-05-20
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Bucheon-si, Busan, Incheon, Seoul, Wŏnju
2024-11-12
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Bucheon-si, Busan, Deagu, Incheon, Seoul, Wŏnju
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 2
588
Seoul
2024-10-11
Recruiting
Boehringer Ingelheim
Phase 1/2
768
Seongnam-si, Seoul
2024-06-28
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Bucheon-si, Seongnam, Seoul
2024-05-06
Active, closed
Boehringer Ingelheim
Phase 3
428
Cheongiu, Goyang, Incheon, Seoul, Suwon
2024-02-09
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT05882058Small Cell Lung Carcinoma, Neuroendocrine Neoplasms, Extra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim
Phase 2
204
Seoul
2023-10-13
Active, closed
Boehringer Ingelheim
Phase 2
268
Cheongju-si, Seoul
2023-09-08
Active, closed
Boehringer Ingelheim
Phase 1
554
Chungju, Seongnam, Seoul
2021-07-02
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seoul

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Seoul that also match the filters currently applied.

How many clinical trials are recruiting in Seoul?

18 of the 27 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seoul), 27 studies
PhaseStudiesRecruitingShare
Phase 3171363%
Phase 26422.2%
Phase 13011.1%
Phase 1/2113.7%

Most active sponsors

Lead sponsors with the most studies (Seoul)
Lead sponsorStudiesRecruiting
Boehringer Ingelheim2718
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.